Department of Orthopedics, Affiliated Xinhua Hospital of Dalian University, Dalian, Liaoning, 116000, China.
Department of Chemistry, University of Georgia, Athens, GA 30602, USA.
Nanomedicine (Lond). 2024;19(23):1867-1878. doi: 10.1080/17435889.2024.2382421. Epub 2024 Aug 7.
We synthesized MgO NPs via sol-gel reaction and investigated them as carriers to deliver Mg to the affected joint for osteoarthritis (OA). The physicochemical properties of samples were characterized by transmission electron microscope (TEM), dynamic light scattering (DLS) and x-ray diffraction (XRD). The release of Mg was monitored by ICP-MS. The potential cytotoxicity was evaluated using MTT assay. The efficacy and biosafety were evaluated in a rabbit OA model. MgO NPs can prolong the Mg release time from 0.5 h to 12 h. No significant cytotoxicity was observed when concentrations below 250 μg/ml. Intra-articular samples could effectively alleviate the degeneration and destruction of the cartilage. this study demonstrates the potential of MgO NPs as a safe and effective treatment of OA. Simultaneously, the size of the particles may play a significant role in influencing the therapeutic outcome.
我们通过溶胶-凝胶反应合成了 MgO NPs,并研究了它们作为载体将镁递送到受影响的关节以治疗骨关节炎 (OA)。通过透射电子显微镜 (TEM)、动态光散射 (DLS) 和 X 射线衍射 (XRD) 对样品的物理化学性质进行了表征。通过 ICP-MS 监测镁的释放。通过 MTT 测定法评估潜在的细胞毒性。在兔骨关节炎模型中评估了疗效和生物安全性。MgO NPs 可以将镁的释放时间从 0.5 小时延长至 12 小时。当浓度低于 250μg/ml 时,没有观察到明显的细胞毒性。关节内样本能有效减轻软骨的退化和破坏。这项研究表明 MgO NPs 具有治疗 OA 的潜力,同时,颗粒的大小可能在影响治疗效果方面发挥重要作用。